Amplitude Ventures↗
Montréal, QuébecCapital catalyst for precision medicine and next-generation medical devices at point of value acceleration.
16 Canadian venture capital firms investing in AI / ML at Growth stage. Browse their thesis focus, check sizes, and recent deals below.
Capital catalyst for precision medicine and next-generation medical devices at point of value acceleration.
Toronto-based VC investing globally in breakthrough clean technology growth companies addressing climate change. Fund III closed at $450M CAD. Selected by Canada VCCI cleantech stream.
A $600M BDC fund following a federal budget commitment. Flexible, multistage and patient capital approach for cleantech entrepreneurs. Portfolio of 50 companies. For every $1 BDC committed, $7.3 was r
A $500M BDC fund targeting late-stage, innovation-based businesses at an inflection point with strong potential for meaningful scale. Invests up to $100M/year in companies leveraging innovative techno
Invest in AI, space, energy, and real estate across North America and Israel through thematic funds.
Private investment firm investing $5M-$30M in high-quality businesses with strong defensible market positions.
Private equity arm of Desjardins Group (Canada's largest cooperative financial group) since 1974. Provides venture and growth capital to Quebec businesses.
Quebec labour-sponsored fund focused on responsible and sustainable investing. Partners with Fonds FTQ, Investissement Québec, and BDC to support Quebec businesses with an emphasis on sustainability.
Largest non-bank venture debt lender globally with $10B+ portfolio. Active lender to Canadian tech and life sciences companies. Publicly traded (NYSE: HTGC). Provides venture debt from $5M-$200M+.
Non-bank venture lending company providing venture debt to VC-backed technology, life sciences, healthcare, and sustainability companies. Publicly traded (NASDAQ: HRZN). Active in the North American m
Growth-stage AI companies with proven product-market fit in Canada and UK.
Vancouver-based PE firm focused on consumer brands. Portfolio generates $1.5B+ in annual retail sales.
Health tech and B2B technology at inflection point between commercialization and scale.
Invest in world-leading companies developing and applying artificial intelligence.
Flexible growth capital solutions (debt, convertible debt, structured equity) to mid-later stage technology companies. $10M-$50M.
North America's Intelligent Industry through software, AI/ML, and IIoT. Digitalization, transformation, and sustainability.